AUTL - Autolus Therapeutics GAAP EPS of -$0.26 in-line
2023-11-02 07:22:24 ET
More on Autolus Therapeutics
- Autolus: CAR-T Therapy Looks Promising
- Autolus Therapeutics: Innovating T Cell Cancer Treatments
- Autolus Therapeutics plc (AUTL) Q2 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Autolus Therapeutics
- Historical earnings data for Autolus Therapeutics
For further details see:
Autolus Therapeutics GAAP EPS of -$0.26 in-line